Design, synthesis and evaluation of novel diaryl-1,5-diazoles derivatives bearing morpholine as potent dual COX-2/5-LOX inhibitors and antitumor agents
- 1 May 2019
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 169, 168-184
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (21602103)
- Public Science and Technology Research Funds Projects of Ocean (201505023)
- National Undergraduate Innovation Program and the National Natural Science Foundation of China (J1210026)
This publication has 33 references indexed in Scilit:
- Requirement for NF-κB signalling in a mouse model of lung adenocarcinomaNature, 2009
- ChemInform Abstract: Aziridines as Intermediates in Diversity-Oriented Syntheses of Alkaloids.ChemInform, 2009
- Stereoselective cyclopropanation of serine- and threonine-derived oxazines to access new morpholine-based scaffoldsOrganic & Biomolecular Chemistry, 2008
- Cancer-related inflammationNature, 2008
- Ligand Coordinate Analysis of SC-558 from the Active Site to the Surface of COX-2: A Molecular Dynamics StudyJournal of Chemical Information and Modeling, 2006
- Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smokeCarcinogenesis, 2005
- Nimesulide and indomethacin induce apoptosis in head and neck cancer cellsJournal of Oral Pathology & Medicine, 2004
- COX‐2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX‐2 inhibitor celecoxibThe FASEB Journal, 2001
- Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agentsNature, 1996
- Self-Promotion? Intimate Connections Between APC and Prostaglandin H Synthase-2Cell, 1996